Centre for Global Health Research, Ghana
Quick facts
Marketed products
- Amodiaquine plus sulphadoxine-pyrimethamine combination · Infectious Disease
This combination inhibits parasite DNA synthesis and folate metabolism through two complementary antimalarial agents that work synergistically against Plasmodium parasites.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Centre for Global Health Research, Ghana portfolio CI brief
- Centre for Global Health Research, Ghana pipeline updates RSS
Frequently asked questions about Centre for Global Health Research, Ghana
What are Centre for Global Health Research, Ghana's marketed drugs?
Top marketed products include Amodiaquine plus sulphadoxine-pyrimethamine combination.
Related
- Amodiaquine plus sulphadoxine-pyrimethamine combination · Infectious Disease
- Sector hub: All tracked pharma companies